Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T89697
|
||||
| Former ID |
TTDS00476
|
||||
| Target Name |
Indoleamine 2,3-dioxygenase
|
||||
| Gene Name |
IDO1
|
||||
| Synonyms |
INDO; IDO; Indoleamine-pyrrole 2,3-dioxygenase; IDO1
|
||||
| Target Type |
Successful
|
||||
| Disease | Cancer [ICD9: 140-229; ICD10: C00-C96] | ||||
| Depression [ICD9: 311; ICD10: F30-F39] | |||||
| Function |
Catalyzes the cleavage of the pyrrol ring of tryptophan and incorporates both atoms of a molecule of oxygen.
|
||||
| BioChemical Class |
Oxidoreductases acting on single donors
|
||||
| Target Validation |
T89697
|
||||
| UniProt ID | |||||
| EC Number |
EC 1.13.11.52
|
||||
| Sequence |
MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVE
KLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLEL PPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKV IPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGN PQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMP PAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQ QPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG |
||||
| Drugs and Mode of Action | |||||
| Inhibitor | 1,2-NAPHTHOQUINONE | Drug Info | [529353] | ||
| 1,4-naphtho-quinone | Drug Info | [529353] | |||
| 1-methyl-L-tryptophan | Drug Info | [532500] | |||
| 1H-indole-4,7-dione | Drug Info | [529405] | |||
| 2,2-dimethyl-2H-benzo[g]chromene-5,10-dione | Drug Info | [529353] | |||
| 2,3-dichloro-1,4-naphthoquinone | Drug Info | [529353] | |||
| 2,3-dihydrobenzo[d]thiazole-2-thiol | Drug Info | [530623] | |||
| 2,4-Dichlorobenzenemethanethiol | Drug Info | [531087] | |||
| 2-(1H-Imidazol-4-yl)benzene-1,3-diol | Drug Info | [529619] | |||
| 2-(1H-Imidazol-4-yl)phenol | Drug Info | [529619] | |||
| 2-Chlorobenzenemethanethiol | Drug Info | [531087] | |||
| 2-hydroxygarveatin E | Drug Info | [528499] | |||
| 2-HYDROXYGARVIN A | Drug Info | [528499] | |||
| 2-methoxy-1,4-naphthoquinone | Drug Info | [529353] | |||
| 3,4-Dichlorobenzenemethanethiol | Drug Info | [531087] | |||
| 3-(1H-Imidazol-4-yl)benzenethiol | Drug Info | [529619] | |||
| 3-(4H-Imidazol-4-yl)benzenethiol | Drug Info | [529619] | |||
| 4-(1H-1,2,3-triazol-5-yl)pyridine | Drug Info | [530623] | |||
| 4-(2-(diethylamino)ethylamino)-1-naphthol | Drug Info | [530623] | |||
| 4-(2-Hydroxyethoxy)-1-naphthol | Drug Info | [530623] | |||
| 4-(Benzylamino)-1-naphthol | Drug Info | [530623] | |||
| 4-(Cyclohexylamino)-1-naphthol | Drug Info | [530623] | |||
| 4-(ethylamino)naphthalen-1-ol | Drug Info | [530623] | |||
| 4-(Isopropylamino)-1-naphthol | Drug Info | [530623] | |||
| 4-(methylamino)naphthalen-1-ol | Drug Info | [530623] | |||
| 4-(Pent-3-ylamino)-1-naphthol | Drug Info | [530623] | |||
| 4-(propylamino)naphthalen-1-ol | Drug Info | [530623] | |||
| 4-(tert-butylamino)naphthalen-1-ol | Drug Info | [530623] | |||
| 4-amino-1,2,5-oxadiazole-3-carboximidamide | Drug Info | [530194] | |||
| 4-aminonaphthalen-1-ol | Drug Info | [530623] | |||
| 4-Chlorobenzenemethanethiol | Drug Info | [531087] | |||
| 4-Fluorobenzenemethanethiol | Drug Info | [531087] | |||
| 4-Methoxybenzenemethanethiol | Drug Info | [531087] | |||
| 4-methoxynaphthalen-1-amine | Drug Info | [530623] | |||
| 4-Methylbenzenemethanethiol | Drug Info | [531087] | |||
| 4-Phenylimidazole | Drug Info | [529619] | |||
| 4-phenylthiazole-2-thiol | Drug Info | [530623] | |||
| 5-(isopropylamino)quinolin-8-ol | Drug Info | [530623] | |||
| 5-aminoquinolin-8-ol | Drug Info | [530623] | |||
| 5-phenyl-1H-1,2,3-triazole | Drug Info | [530623] | |||
| amg-1 | Drug Info | [531599] | |||
| ANNULIN A | Drug Info | [528499] | |||
| ANNULIN B | Drug Info | [528499] | |||
| ANNULIN C | Drug Info | [528499] | |||
| BENZENEMETHANETHIOL | Drug Info | [531087] | |||
| BLV-0801 | Drug Info | [543722] | |||
| compound 5i | Drug Info | [532500] | |||
| Exiguamine A | Drug Info | [529405] | |||
| EXIGUAMINE B | Drug Info | [529627] | |||
| GARVEATIN A | Drug Info | [528499] | |||
| Garveatin C | Drug Info | [528499] | |||
| Garveatin E | Drug Info | [528499] | |||
| INCB24360 | Drug Info | [551022] | |||
| JUGLONE | Drug Info | [529353] | |||
| N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate | Drug Info | [527977] | |||
| Naphthalene-1,4-diol | Drug Info | [530623] | |||
| S-(2,4-Dichlorobenzyl)isothiourea hydrobromide | Drug Info | [531087] | |||
| S-(2-Chlorobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(3,4-Dichlorobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(3-Chlorobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Bromobenzyl)isothiourea hydrobromide | Drug Info | [531087] | |||
| S-(4-Chlorobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Cyanobenzyl)isothiourea hydrobromide | Drug Info | [531087] | |||
| S-(4-Ethylbenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Fluorobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Methoxybenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Methylbenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-(4-Nitrobenzyl)isothiourea hydrochloride | Drug Info | [531087] | |||
| S-Benzyl-brassinin | Drug Info | [527977] | |||
| Seco-exiguamine | Drug Info | [529627] | |||
| tryptanthrin | Drug Info | [532500] | |||
| Binder | L-Tryptophan | Drug Info | [536247] | ||
| Pathways | |||||
| BioCyc Pathway | Superpathway of tryptophan utilization | ||||
| Tryptophan degradation | |||||
| L-kynurenine degradation | |||||
| Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | |||||
| NAD de novo biosynthesis | |||||
| KEGG Pathway | Tryptophan metabolism | ||||
| Metabolic pathways | |||||
| African trypanosomiasis | |||||
| NetPath Pathway | TSLP Signaling Pathway | ||||
| IL5 Signaling Pathway | |||||
| TGF_beta_Receptor Signaling Pathway | |||||
| PathWhiz Pathway | Tryptophan Metabolism | ||||
| Reactome | Tryptophan catabolism | ||||
| WikiPathways | Tryptophan metabolism | ||||
| Metabolism of amino acids and derivatives | |||||
| References | |||||
| Ref 524471 | ClinicalTrials.gov (NCT01961115) INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma. U.S. National Institutes of Health. | ||||
| Ref 542179 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 717). | ||||
| Ref 527977 | J Med Chem. 2006 Jan 26;49(2):684-92.Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. | ||||
| Ref 528499 | J Nat Prod. 2006 Oct;69(10):1496-9.Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata. | ||||
| Ref 529353 | J Med Chem. 2008 Mar 27;51(6):1706-18. Epub 2008 Mar 5.Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. | ||||
| Ref 529405 | J Med Chem. 2008 May 8;51(9):2634-7. Epub 2008 Apr 8.Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A. | ||||
| Ref 529619 | J Med Chem. 2008 Aug 28;51(16):4968-77. Epub 2008 Jul 30.Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase. | ||||
| Ref 529627 | Nat Chem Biol. 2008 Sep;4(9):535-7.Biomimetic synthesis of the IDO inhibitors exiguamine A and B. | ||||
| Ref 530194 | J Med Chem. 2009 Dec 10;52(23):7364-7.Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model. | ||||
| Ref 530623 | J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors. | ||||
| Ref 531087 | Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. Epub 2010 Jul 11.S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase. | ||||
| Ref 531599 | Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochim Biophys Acta. 2011 Dec;1814(12):1947-54. | ||||
| Ref 532500 | Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. J Med Chem. 2013 Nov 14;56(21):8321-31. | ||||
| Ref 536247 | Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Biochemistry. 2006 Jul 18;45(28):8527-38. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.